Answers are grounded in this paper and cite their sources.
Findings reveal metabolic reprogramming linked to tumor growth in intrahepatic cholangiocarcinoma, suggesting SPINK1 as a therapeutic target.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Rong et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: